Answers are grounded in this paper and cite their sources.
Background Deep vein thrombosis (DVT) in critically ill patients is often undetected and could lead to pulmonary embolism (PE) and subsequent morbidity and mortality. Ultrasound surveillance for DVT may facilitate early detection and treatment of DVTs in high-risk medical-surgical ICU patients and thus may improve patient outcomes. Objective The Diagnosing deep-vein thrombosis early in critically ill patients (DETECT) trial aims to evaluate the effect of twice-weekly surveillance bilateral lower limb ultrasound compared to usual care on 90-day mortality of critically ill adults admitted to medical, surgical, and trauma ICUs. Methods/Design In this multicenter randomized trial, critically ill patients will be randomized to twice-weekly surveillance bilateral lower limb ultrasound (surveillance group) or usual care group. The primary outcome is 90-day mortality. The trial has 80% power to detect a 6% absolute risk reduction in 90-day mortality from 30 to 24%. Secondary outcomes include lower limb proximal DVT, pulmonary embolism and clinically important bleeding. Results As of May 31, 2026 a total of 1721 patients have been recruited from 15 centers across Saudi Arabia and Kuwait. Discussion This statistical analysis plan for the DETECT Trial was developed following international guidelines. This plan specifies a priori the statistical methods for evaluating primary and secondary outcomes and defines covariables for adjusted analyses. Trial registration Clinicaltrials.gov NCT05112705 (registered on 2021-10-26 and posted on 2021-11-09 after quality check).
No takes yet. Share an insight, caveat, or question.
Arabi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: